MC
BHC icon

Moors & Cabot’s Bausch Health BHC Stock Holding History

Moors & Cabot’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,550
Closed -$246K – 511
2018
Q3 		$246K Sell
9,550
-12,400
-56% -$284K 0.03% 472
2018
Q2 		$509K Buy
21,950
+200
+0.9% +$4.14K 0.07% 299
2018
Q1 		$346K Sell
21,750
-100
-0.5% -$1.86K 0.05% 398
2017
Q4 		$455K Sell
21,850
-1,825
-8% -$28.9K 0.06% 329
2017
Q3 		$337K Buy
23,675
+8,400
+55% +$127K 0.05% 381
2017
Q2 		$267K Buy
15,275
+3,725
+32% +$44.7K 0.04% 409
2017
Q1 		$129K Buy
+11,550
New +$159K 0.02% 485
2016
Q4 		– Sell
-13,208
Closed -$324K – 545
2016
Q3 		$324K Buy
+13,208
New +$342K 0.05% 355

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Moors & Cabot's BHC Position: Q4 2018 in Review

Moors & Cabot sold out of Bausch Health (BHC) in Q4 2018, closing a stake of 9,550 shares — an estimated $246K sold.

Moors & Cabot first reported a position in BHC in Q3 2016 and held it in 8 quarters. The position peaked at $509K in Q2 2018. 334 funds tracked by Wall St. Rank hold BHC as of Q4 2018.

  • Moors & Cabot reported no remaining Bausch Health position as of Q4 2018 after selling out during the quarter.
  • Moors & Cabot sold 9,550 Bausch Health shares in Q4 2018, an estimated $246K.
  • Moors & Cabot first reported a position in Bausch Health in Q3 2016 and held it in 8 quarters.
  • Moors & Cabot's Bausch Health position peaked at $509K in Q2 2018.
  • 334 funds tracked by Wall St. Rank held Bausch Health as of Q4 2018.

Based on Moors & Cabot's 13F filing for Q4 2018, filed 13 Feb 2019.